LexaGene Holdings Inc. (CVE:LXG – Get Free Report) fell 19.2% during trading on Thursday . The stock traded as low as C$0.10 and last traded at C$0.11. 2,135,375 shares changed hands during trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Stock Performance
The company has a quick ratio of 1.13, a current ratio of 1.39 and a debt-to-equity ratio of 138.01. The stock has a market cap of C$14.77 million, a price-to-earnings ratio of -1.31 and a beta of 2.26. The company has a 50 day simple moving average of C$0.11 and a 200 day simple moving average of C$0.11.
LexaGene Company Profile
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Featured Stories
- Five stocks we like better than LexaGene
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Most Volatile Stocks, What Investors Need to Know
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- Want to Profit on the Downtrend? Downtrends, Explained.
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
